Clinical trials
Terminated Lymphoma, Mantle-Cell trials in Australia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
7 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2012 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2019 | 1 |
| 2022 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 7 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Atara Biotherapeutics | 1 |
| Baxalta now part of Shire | 1 |
| IGM Biosciences, Inc. | 1 |
| Janssen Research & Development, LLC | 1 |
| Novartis Pharmaceuticals | 1 |
| Peter MacCallum Cancer Centre, Australia | 1 |
| TG Therapeutics, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lymphoma, Follicular | 7 |
| Lymphoma, Mantle-Cell | 7 |
| Lymphoma, B-Cell, Marginal Zone | 5 |
| Lymphoma, Large B-Cell, Diffuse | 5 |
| Lymphoma, Non-Hodgkin | 4 |
| Lymphoma | 3 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 2 |
| Burkitt Lymphoma | 1 |
| Epstein-Barr Virus Infections | 1 |
| Graft vs Host Disease | 1 |
Trials
Showing 1 to 7 of 7. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.